发明名称 |
Substituierte 2-(2,6-Dioxopiperidin-3-yl)-phthalimide und Oxoisoindoline und Verfahren zur Verringerung der TNF-Alpha-Stufen |
摘要 |
<p>Substituted 2-(2,6-dioxopiperidin-3-yl)phtalimides and l-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF alpha in a mammal. Typical embodiments are 1-oxo-2(2,6-dioxo-3-methylpiperidin-3-yl)-4,5,6,7-tetrafluoroisoindoline and 1,3-dioxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4-aminoisoindoline.</p> |
申请公布号 |
DE69740140(D1) |
申请公布日期 |
2011.04.14 |
申请号 |
DE1997640140 |
申请日期 |
1997.07.24 |
申请人 |
CELGENE CORP. |
发明人 |
MULLER, GEORGE W;STIRLING, DAVID;CHEN, ROGER SHEN-CHU |
分类号 |
C07D401/04;A61K31/4439;A61K31/445;A61K31/454;A61P1/00;A61P1/04;A61P7/00;A61P9/02;A61P9/04;A61P9/10;A61P17/06;A61P19/00;A61P19/02;A61P29/00;A61P31/06;A61P33/06;A61P35/00;A61P37/02;A61P37/06;A61P43/00 |
主分类号 |
C07D401/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|